TrueCAGR

UPL Limited

NSE: UPLBSE: 512070ISIN INE628A01036Face value ₹2standalone
₹572
+0.53% · 2026-11-20 · 52-wk ₹484–₹805
Source: BSE filings · Financials to FY2026 · 8 years of history · Data last updated: results filed 2 Nov 2026, prices to 20 Nov 2026 · How we calculate thisconsolidatedstandalone
Section 02 · Synthesis

What stands out?

The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.

StrengthConcernWatchContext
WatchTalking point

Volatile earnings

Profit has swung sharply over 7 years (from ₹-1,878 to ₹4,437) — one year is a weak guide to the earnings power.

Importance 62 / 95 · growth

Strength

Earnings consistently backed by cash

Operating cash flow has matched or exceeded reported profit in 5 of the last 5 profit-making years (latest 3.54×).

Importance 55 / 95 · cash quality

StrengthTalking point

Book value compounding

Net worth compounded at 12.6% a year over 7 years (₹18,003 → ₹41,269).

Importance 53 / 95 · financial health

Section 03 · The company

Who is this company?

Classified by the exchange under Commodities › Chemicals › Fertilizers & Agrochemicals › Pesticides & Agrochemicals.

Market cap
₹48,334 cr
FY2026 revenue
₹5,748 cr
FY2026 net profit
₹785 cr
Net worth
—
Total debt
—net cash
EPS (basic)
₹9.46
Listed
NSE · BSE
Reporting
Ind-ASApr–Mar

Peer set used on this page: 2 pesticides & agrochemicals.

Section 04 · Business performance

Is the business growing?

Revenue fell 5.7% a year over 7 years, from ₹8,660 cr in FY2019 to ₹5,748 cr in FY2026 (includes the Feb 2019 acquisition of Arysta LifeScience). Net profit grew 9.9% a year over the same period.

Revenue & net profit — FY19 to FY26₹ crore · consolidated
₹'000 cr05101520023REVENUENET PROFIT9k405FY1910k461FY2011k220FY2116k1,176FY2219k975FY235k1,208FY245k2,939FY256k785FY26
RevenueNet profit
Watch

Profit has swung sharply over 7 years (from ₹-1,878 to ₹4,437) — one year is a weak guide to the earnings power.

Rule EARNINGS_VOLATILE

Revenue growth per year
−5.7%over 7 years (FY19–FY26)
Revenue growth
+7.8%vs last year
Net profit growth
−73.3%vs last year
Change in net profit since FY19
+94%

Revenue compounded at 13.1% a year over 7 years (₹21,837 → ₹51,839) — though FY2020 saw a one-off step-change of 64% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.

Net profit rose 170.7% to ₹2,220 — but FY2025 was a depressed ₹820 (vs a ~₹2,837 historical norm), so this is a recovery. Profit has compounded 5.6% a year over 7 years.

Section 05 · Recent activity

What changed recently?

In Q2 FY27 (Jul–Sep 2026), revenue was ₹11,860 cr (down 1.3% on the same quarter last year) and net profit ₹452 cr (down 26.1%).

Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.

Concern

Q2 FY27 net profit was ₹452 cr, down 26.1% from ₹612 cr a year earlier.

Rule QTR_PROFIT_GROWTH_YOY

Watch

Q2 FY27 net profit declined 26.1% while revenue declined 1.3% vs the same quarter last year — a gap of 24.8 percentage points.

Rule QTR_PROFIT_VS_REVENUE_GROWTH

Strength

Q2 FY27 revenue was ₹11,860 cr, up 16.5% from ₹10,181 cr in the previous quarter (Q1 FY27).

Rule QTR_REVENUE_SEQUENTIAL_CHANGE

A. Quarterly results

Latest quarters — Q3 '25 to Q2 '27₹ crore · consolidated
₹'000 cr05101520012REVENUENET PROFIT11k853Q3 '2516k1,079Q4 '259k-176Q1 '2612k612Q2 '2612k490Q3 '2618k1,294Q4 '2610k-73Q1 '2712k452Q2 '27
RevenueNet profit
QuarterRevenueYoYNet profitYoYNet margin
Q3 FY2510,907+10.3%853−153.1%7.8%
Q4 FY2515,573+10.6%1,079−1448.8%6.9%
Q1 FY269,216+1.6%−176−66.6%−1.9%
Q2 FY2612,019+8.4%612−204.6%5.1%
Q3 FY2612,269+12.5%490−42.6%4.0%
Q4 FY2618,335+17.7%1,294+19.9%7.1%
Q1 FY2710,181+10.5%−73−58.5%−0.7%
Q2 FY2711,860−1.3%452−26.1%3.8%

B. TTM snapshot

Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters

Revenue
₹52,645 crTTM
EBITDA
₹10,198 crTTM
EBIT
₹6,805 crTTM
PBT
₹3,442 crTTM
Net profit
₹2,163 crTTM

C. Corporate actions

17 Jul 2026DividendFinal Dividend - Rs. - 6.0000 — ₹6.00/share
11 Jul 2025DividendFinal Dividend - Rs. - 6.0000 — ₹6.00/share
26 Nov 2024Rights issueRight Issue of Equity Shares
12 Aug 2024DividendFinal Dividend - Rs. - 1.0000 — ₹1.00/share
3 Aug 2023DividendFinal Dividend - Rs. - 10.0000 — ₹10.00/share
27 Jul 2022DividendFinal Dividend - Rs. - 10.0000 — ₹10.00/share
14 Jul 2021DividendFinal Dividend - Rs. - 10.0000 — ₹10.00/share
19 Aug 2020DividendDividend - Rs. - 6.0000 — ₹6.00/share
2 Jul 2019Bonus issueBonus issue 1:2 — 2:3
28 May 2019DividendDividend - Rs. - 8.0000 — ₹8.00/share
9 Aug 2018DividendDividend - Rs. - 8.0000 — ₹8.00/share
22 Jun 2017DividendDividend - Rs. - 7.0000 — ₹7.00/share
16 Jun 2016DividendDividend - Rs. - 5.0000 — ₹5.00/share
16 Jul 2015DividendDividend - Rs. - 5.0000 — ₹5.00/share
7 Aug 2014DividendDividend - Rs. - 4.0000 — ₹4.00/share
4 Jul 2013DividendDividend - Rs. - 2.5000 — ₹2.50/share
12 Jul 2012DividendFinal Dividend - Rs. - 0.5000 — ₹0.50/share
3 Apr 2012DividendInterim Dividend - Rs. - 2.0000 — ₹2.00/share
14 Jul 2011DividendDividend - Rs. - 2.0000 — ₹2.00/share
26 Aug 2010DividendDividend - Rs. - 2.0000 — ₹2.00/share
3 Sept 2009DividendDividend - Rs. - 1.5000 — ₹1.50/share
29 Oct 2008Bonus issueBonus issue 1:1 — 1:2
4 Sept 2008DividendDividend - Rs. - 2.0000 — ₹2.00/share
28 Sept 2005Otherother
4 Dec 2003Scheme of arrangementScheme of Arrangement
Section 06 · Business performance

Is it becoming more profitable?

EBITDA margin was 22.5% in FY2026, against 16.2% in FY2019. ROE was 30.1% and ROCE 1.5% in FY2025.

Margins — FY19 to FY26% of revenue · consolidated
0%5%10%15%20%25%30%35%40%45%50%55%22.5%11.8%FY19FY20FY21FY22FY23FY24FY25FY26
EBITDA marginNet margin
Concern

ROE of 5.6% is below the pesticides and agrochemicals median of 9.0%.

Rule ROE_BELOW_PEER_MEDIAN

EBITDA margin now
22.5%
8-year range
5.6–22.5%
ROE FY2026
30.1%
ROCE FY2026
1.5%

ROE rose from 2.3% to 5.6% — but FY2025 was a depressed year, so this is a rebound rather than a step-up.

EBITDA margin improved from 17.3% to 19.2% of revenue.

EBITDA margin has ranged from 11.7% to 22.3% over 7 years and sits at 19.2% now.

Section 07 · Financial health

Is financial health improving?

It had little or no debt in FY2025 (debt-to-equity 0.05x). Operating cash flow was -2.86x net profit.

Net worth — FY19 to FY26₹ crore · consolidated
₹'000 cr0713208kFY198kFY208kFY218kFY227kFY238kFY2412kFY25FY26
Net worth (shareholders' funds)
Strength

Operating cash flow has matched or exceeded reported profit in 5 of the last 5 profit-making years (latest 3.54×).

Rule CFO_CONSISTENTLY_EXCEEDS_PAT

Operating cash flow vs net profit₹ crore · FY21–FY26
0k1k2k3k2k220FY212k1kFY222k975FY23-4111kFY24-9233kFY25-2k785FY26
Operating cash flowNet profit
Total debt
—
Operating cash flow ÷ net profit
-2.86×FY2026
Free cash flow
₹−2,279 cr
Current ratio
1.62×

Net worth compounded at 12.6% a year over 7 years (₹18,003 → ₹41,269).

Free cash flow has been positive in 6 of the last 6 years.

Operating profit covers interest only 1.97× (FY2026).

Section 08 · Relative position

How does it compare with peers?

Its peer group is too small for a meaningful ranking.

Ranked against 2 pesticides & agrochemicals (FY2026, consolidated). No peer-relative rule fired for this company.

Not enough peers in this set report the underlying metrics yet for a ranking.

P / E
22.3×TTM to Sept 26
P / B
1.2×latest book
P / S
0.9×TTM sales
Earnings yield
4.5%TTM to Sept 26

On the trailing twelve months. Last full year: P/E 21.8× · P/S 0.9× · ROE 5.6%.

Section 09 · The stock

How has the stock performed?

The share price is down 24.1% over 1 year, up 1.6% over 3 years (0.5% a year) and down 22.9% over 5 years (−5.1% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 29.0% below its 52-week high.

Adjusted close — 2020-01 to 2026-11₹ per share · split / bonus adjusted
0k₹5722020202120222023202420252026

Long-term price performance is shown above.

1-year return
−24.1%
3-year return
+1.6%
5-year return
−22.9%
From 52-wk high
−29.0%
Section 10 · Technical data

What does the technical data say?

Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.

vs 50-day avg
Above₹538
vs 200-day avg
Below₹605
RSI (14)
64.8neutral
MACD histogram
4.5
From 52-wk high
−29.0%
From 52-wk low
+18.2%
30-day volatility
34.1%ann.
6-month return
−9.8%
RSI (14) · 0–10064.8 — neutral
0305070100OVERSOLDOVERBOUGHT64.8
Section 11 · Open questions

What should I investigate further?

Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.

  • Watch
    Volatile earnings
    Profit has swung sharply over 7 years (from ₹-1,878 to ₹4,437) — one year is a weak guide to the earnings power.
    EARNINGS_VOLATILE · conviction 62
  • Concern
    Less profitable than peers
    ROE of 5.6% is below the pesticides and agrochemicals median of 9.0%.
    ROE_BELOW_PEER_MEDIAN · conviction 50
  • Concern
    Thin interest cover
    Operating profit covers interest only 1.97× (FY2026).
    INTEREST_COVER_LOW · conviction 43
  • Cash-flow-statement facts are unavailable for FY2019, FY2020 — those filings predate SEBI's Cash Flow Statement disclosure requirement. All other loaded years carry full P&L, balance sheet and cash-flow data.
  • The price-adjusted series does not correct for a rights issue (ex-date 2024-11-26) — BSE's corporate-actions feed does not carry the subscription price or ratio a rights adjustment needs, unlike splits and bonuses, which are corrected. Returns spanning that date may be modestly overstated or understated.
Section 12 · Reference

The numbers

The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.

Income & balance sheet — ₹ crore, consolidated
MetricFY19FY20FY21FY22FY23FY24FY25FY26
Revenue8,6609,64111,34516,44918,7835,3985,3305,748
Total income9,22010,14711,45817,08019,2456,2025,4776,654
EBITDA1,3991,7111,7332,6882,7461,2052991,296
Profit before tax4865384341,2611,2849312,0451,013
Net profit4054612201,1769751,2082,939785
EPS (₹)8.06.02.915.413.016.138.19.5
Net worth7,9728,0247,7868,2017,0687,53012,021—
Total debt1,3659971,0871,6655661,827570—
Operating cash flow——1,8202,3491,667−411−923−2,243
Free cash flow——6561,303560−1,073−1,178−2,279
Key ratios — consolidated
RatioFY19FY20FY21FY22FY23FY24FY25FY26
Growth
Revenue growth YoY—11.317.745.014.2-71.3-1.37.8
Profit growth YoY—13.8-52.3434.5-17.123.9143.3-73.3
Profitability
EBITDA margin %16.217.715.316.314.622.35.622.5
Net margin %4.44.51.96.95.119.553.711.8
Return on equity %5.15.82.814.712.816.630.1—
Return on capital %7.28.98.417.520.512.71.5—
Leverage & cash
Debt to equity0.170.120.140.200.080.240.05—
Cash flow ÷ profit——8.272.001.71-0.34-0.31-2.86
Current ratio1.141.121.071.141.060.841.62—
Financials: BSE Integrated Filing inline XBRL (SEBI taxonomy), normalised to standard metric keys. Prices: end-of-day — history loaded from NSE end-of-day files, new days from the BSE bhavcopy; raw OHLC preserved; a corporate-action factor produces the adjusted series. The insight engine writes factual observations from fixed rules — it does not make recommendations. Not investment advice.